Crestline Management’s Health Assurance Acquisition Corp. Class A Common Stock HAAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-40,000
Closed -$395K 304
2022
Q2
$395K Buy
40,000
+27,853
+229% +$275K 0.05% 176
2022
Q1
$120K Sell
12,147
-5,853
-33% -$57.4K 0.01% 235
2021
Q4
$176K Hold
18,000
0.01% 202
2021
Q3
$176K Buy
+18,000
New +$176K 0.02% 211

Other funds holding HAAC

Crestline Management's HAAC Position: Q3 2022 in Review

Crestline Management sold out of Health Assurance Acquisition Corp. Class A Common Stock (HAAC) in Q3 2022, closing a stake of 40,000 shares — an estimated $395K sold.

Crestline Management first reported a position in HAAC in Q3 2021 and held it in 4 quarters. The position peaked at $395K in Q2 2022. 85 funds tracked by Wall St. Rank hold HAAC as of Q3 2022.

  • Crestline Management reported no remaining Health Assurance Acquisition Corp. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Crestline Management sold 40,000 Health Assurance Acquisition Corp. Class A Common Stock shares in Q3 2022, an estimated $395K.
  • Crestline Management first reported a position in Health Assurance Acquisition Corp. Class A Common Stock in Q3 2021 and held it in 4 quarters.
  • Crestline Management's Health Assurance Acquisition Corp. Class A Common Stock position peaked at $395K in Q2 2022.
  • 85 funds tracked by Wall St. Rank held Health Assurance Acquisition Corp. Class A Common Stock as of Q3 2022.

Based on Crestline Management's 13F filing for Q3 2022, filed 14 Nov 2022.